Insights from 2023 WCLC


 

WCLC 2023 Insights: "ILLUMINATE - Efficacy & Safety of Durvalumab-Tremelimumab & Chemotherapy in EGFRm NSCLC Following Progression on EGFR Inhibitors"

76 views
September 22, 2023
0 Comments
Login to view comments. Click here to Login
Videos